Yüklüyor......
Clonazepam monotherapy for treating people with newly diagnosed epilepsy
BACKGROUND: Epilepsy is one of the most common neurological disorders worldwide, with an age‐adjusted prevalence of 4 to 8 per 1000 population and an age‐adjusted incidence of 44 per 100,000 person‐years in developed countries. Monotherapy represents the best therapeutic option in people with newly...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2019
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863099/ https://ncbi.nlm.nih.gov/pubmed/31742671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013028.pub2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|